Suppr超能文献

HIV-1逆转录酶/核糖核酸酶H:利用聚合酶链反应构建的质粒在大肠杆菌中的高水平表达。

HIV-1 reverse transcriptase/ribonuclease H: high level expression in Escherichia coli from a plasmid constructed using the polymerase chain reaction.

作者信息

D'Aquila R T, Summers W C

机构信息

Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.

出版信息

J Acquir Immune Defic Syndr (1988). 1989;2(6):579-87.

PMID:2479733
Abstract

The human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT)/ribonuclease H has been expressed to high levels in Escherichia coli from a recombinant plasmid constructed using the polymerase chain reaction (PCR) for in vitro mutagenesis. Translational initiation and termination codons were introduced by the PCR at points corresponding to sites of cleavage of the RT from the gag-pol precursor polyprotein by the HIV-1 protease; the HIV-1 protease is not expressed from this construct. Most of the RT coding sequences derived from PCR were exchanged for a DNA fragment cloned by standard methods to minimize the possibility that an unwanted mutation was introduced during the in vitro amplification. The RT is expressed in bacteria from this plasmid as 66 and 51 kDa proteins, has both RNA-dependent DNA polymerase and ribonuclease H (RNase H) activities, and is indistinguishable from native HIV-1 RT in electrophoretic mobility and immunoreactivity. Peptide sequencing of the amino terminus of the HIV-1 RT purified from bacterial lysates is also presented. A novel activity gel assay was used to confirm that only the 66 kd protein catalyzes the RNase H reaction; this assay will simplify analysis of this catalytic activity. This HIV-1 RT expression plasmid is of interest because of the high level of expression in bacteria and the demonstrated RNase H activity of the enzyme. This plasmid will be distributed for research purposes through the NIH AIDS Repository and will facilitate enzymologic, structural, and immunologic evaluation of reverse transcription and its chemotherapeutic inhibition.

摘要

1型人类免疫缺陷病毒(HIV-1)逆转录酶(RT)/核糖核酸酶H已通过使用聚合酶链反应(PCR)构建的重组质粒在大肠杆菌中高水平表达,该重组质粒用于体外诱变。通过PCR在与HIV-1蛋白酶从gag-pol前体多蛋白切割RT的位点相对应的位置引入翻译起始和终止密码子;该构建体不表达HIV-1蛋白酶。大部分源自PCR的RT编码序列被换成通过标准方法克隆的DNA片段,以尽量减少在体外扩增过程中引入不需要的突变的可能性。RT以66 kDa和51 kDa的蛋白质形式在细菌中从该质粒表达,具有RNA依赖性DNA聚合酶和核糖核酸酶H(RNase H)活性,并且在电泳迁移率和免疫反应性方面与天然HIV-1 RT无法区分。还展示了从细菌裂解物中纯化的HIV-1 RT氨基末端的肽序列分析。使用一种新型活性凝胶测定法来确认只有66 kd的蛋白质催化RNase H反应;该测定法将简化对这种催化活性的分析。这种HIV-1 RT表达质粒因其在细菌中的高水平表达以及该酶已证实的RNase H活性而备受关注。该质粒将通过美国国立卫生研究院艾滋病储存库分发用于研究目的,并将促进对逆转录及其化学治疗抑制的酶学、结构和免疫学评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验